Cellebrite DI (CLBT) Short-term Investments (2020 - 2025)
Cellebrite DI has reported Short-term Investments over the past 5 years, most recently at $161.0 million for Q4 2025.
- Quarterly results put Short-term Investments at $161.0 million for Q4 2025, up 4.75% from a year ago — trailing twelve months through Dec 2025 was $161.0 million (up 4.75% YoY), and the annual figure for FY2025 was $161.0 million, up 4.75%.
- Short-term Investments for Q4 2025 was $161.0 million at Cellebrite DI, up from $153.7 million in the prior quarter.
- Over the last five years, Short-term Investments for CLBT hit a ceiling of $161.0 million in Q4 2025 and a floor of $38.7 million in Q4 2023.
- Median Short-term Investments over the past 4 years was $99.2 million (2022), compared with a mean of $99.5 million.
- Biggest five-year swings in Short-term Investments: dropped 13.33% in 2023 and later soared 297.35% in 2024.
- Cellebrite DI's Short-term Investments stood at $44.6 million in 2022, then dropped by 13.33% to $38.7 million in 2023, then soared by 297.35% to $153.7 million in 2024, then rose by 4.75% to $161.0 million in 2025.
- The last three reported values for Short-term Investments were $161.0 million (Q4 2025), $153.7 million (Q4 2024), and $38.7 million (Q4 2023) per Business Quant data.